The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins

Journal of Endocrinology

Volumn 206, Issue 3, 2010, Pages 249-259

  Ahmed, S F ^a   Farquharson, C ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3;

BONE DEVELOPMENT; BONE GROWTH; GROWTH PLATE; HORMONAL THERAPY; HORMONE ACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; BONE DEVELOPMENT; GROWTH; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MICE; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 77955613356     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0045     Document Type: Review

References (121)

1. Abe T, Nomura S, Nakagawa R, Fujimoto M, Kawase I & Naka T 2006 Osteoblast differentiation is impaired in SOCS-1-deficient mice. Journal of Bone and Mineral Metabolism 24 283-290. (doi:10.1007/s00774-006-0685-0) (Pubitemid 43992671)
2. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ & Billestrup N 1998 Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. Journal of Biological Chemistry 273 1285-1287. (doi:10.1074/jbc.273.3.1285) (Pubitemid 28133642)
3. Akeno N, Robins J, Zhang M, Czyzyk-Krzeska MF & Clemens TL 2002 Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143 420-425. (doi:10.1210/en.143.2.420) (Pubitemid 34107194)
4. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM et al. 1999 SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98 597-608. (doi:10.1016/S0092-8674(00) 80047-1) (Pubitemid 29418951)
5. Andiran N & Yordam N 2007 TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy. Growth Hormone & IGF Research 17 149-153. (doi:10.1016/j.ghir.2007. 01.002) (Pubitemid 46523777)
6. Aubin JE, Lian JB & Stein GS 2006 Bone formation: maturation and functional activities of osteoblast lineage cells. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th ed., pp 20-29. Ed. Favus MJ. Washington DC: American Society for Bone and Mineral Research.
7. Auernhammer CJ, Bousquet C & Melmed S 1999 Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. PNAS 96 6964-6969. (doi:10.1073/pnas.96.12.6964)
8. Baker J, Liu JP, Robertson EJ & Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 73-82. (doi:10.1016/S0092-8674(05)80085-6) (Pubitemid 23306022)
9. Ballesteros M, Leung KC, Ross RJ, Iismaa TP & Ho KK 2000 Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. Journal of Clinical Endocrinology and Metabolism 85 2865-2871. (doi:10.1210/jc.85.8.2865) (Pubitemid 32269165)
10. Barnard R, Haynes KM, Werther GA & Waters MJ 1988 The ontogeny of growth hormone receptors in the rabbit tibia. Endocrinology 122 2562-2569. (doi:10.1210/endo-122-6-2562)
11. Beamer WH & Eicher EM 1976 Stimulation of growth in the little mouse. Journal of Endocrinology 71 37-45. (doi:10.1677/joe.0.0710037)
12. Behringer RR, Lewin TM, Quaife CJ, Palmiter RD, Brinster RL & D'Ercole AJ 1990 Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127 1033-1040. (doi:10.1210/endo-127-3-1033)
13. Blackburn A, Schmitt A, Schmidt P, Wanke R, Hermanns W, Brem G & Wolf E 1997 Actions and interactions of growth hormone and insulinlike growth factor-II: body and organ growth of transgenic mice. Transgenic Research 6 213-222. (doi:10.1023/A:1018494108654) (Pubitemid 27218645)
14. Bougnères P & Goffin V 2007 The growth hormone receptor in growth. Endocrinology and Metabolism Clinics of North America 36 1-16.
15. Burch WM, Corda G, Kopchick JJ & Leung FC 1985 Homologous and heterologous growth hormones fail to stimulate avian cartilage growth in vitro. Journal of Clinical Endocrinology and Metabolism 60 747-750. (doi:10.1210/jcem-60-4-747) (Pubitemid 15147565)
16. Canalis E 1980 Effect of insulin-like growth factor I on DNA and protein synthesis in cultured rat calvaria. Journal of Clinical Investigation 66 709-719. (doi:10.1172/JCI109908) (Pubitemid 10060939)
17. Canalis E, Centrella M, Burch W & McCarthy TL 1989 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. Journal of Clinical Investigation 83 60-65. (doi:10.1172/ JCI113885) (Pubitemid 19048405)
18. Darnell JE Jr 1997 STATs and gene regulation. Science 277 1630-1635. (doi:10.1126/science.277.5332.1630)
19. Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL & van Wyk JJ 1972 Somatomedin: proposed designation for sulphation factor. Nature 235 107. (doi:10.1038/235107a0)
20. Delany AM, Durant D & Canalis E 2001 Glucocorticoid suppression of IGF I transcription in osteoblasts. Molecular Endocrinology 15 1781-1789. (doi:10.1210/me.15.10.1781) (Pubitemid 32939308)
21. Dey BR, Spence SL, Nissley P & Furlanetto RW 1998 Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. Journal of Biological Chemistry 273 24095-24101. (doi:10.1074/jbc.273.37.24095) (Pubitemid 28435753)
22. van der Eerden BC, Karperien M & Wit JM 2003 Systemic and local regulation of the growth plate. Endocrine Reviews 24 782-801. (doi:10.1210/er.2002-0033) (Pubitemid 38067699)
23. Favre H, Benhamou A, Finidori J, Kelly PA & Edery M 1999 Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Letters 453 63-66. (doi:10.1016/S0014-5793(99)00681-X) (Pubitemid 29335474)
24. Fiorelli G, Formigli L, Zecchi Orlandini S, Gori F, Falchetti A, Morelli A, Tanini A, Benvenuti S & Brandi ML 1996 Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18 269-276. (doi:10.1016/8756-3282(95)00485-8) (Pubitemid 26118124)
25. Fox SW, Haque SJ, Lovibond AC & Chambers TJ 2003 The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. Journal of Immunology 170 3679-3687.
26. Fuller K, Lean JM, Bayley KE, Wani MR & Chambers TJ 2000 A role for TGFbeta(1) in osteoclast differentiation and survival. Journal of Cell Science 113 2445-2453. (Pubitemid 30599346)
27. Gazzerro E & Canalis E 2006 Bone morphogenetic proteins and their antagonists. Reviews in Endocrine and Metabolic Disorders 7 51-65. (doi:10.1007/s11154-006-9000-6) (Pubitemid 46044349)
28. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC & Wit JM 2002 Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. Journal of Bone and Mineral Research 17 1408-1419. (doi:10.1359/jbmr.2002.17.8.1408) (Pubitemid 34803825)
29. Goldenberg N & Barkan A 2007 Factors regulating growth hormone secretion in humans. Endocrinology and Metabolism Clinics of North America 36 37-55. (doi:10.1016/j.ecl.2006.11.003) (Pubitemid 46320858)
30. Goldshmit Y, Walters CE, Scott HJ, Greenhalgh CJ & Turnley AM 2004 SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation. Journal of Biological Chemistry 279 16349-16355. (doi:10.1074/jbc.M312873200) (Pubitemid 38509331)
31. Green H, Morikawa M & Nixon T 1985 A dual effector theory of growthhormone action. Differentiation 29 195-198. (doi:10.1111/j.1432-0436.1985. tb00316.x) (Pubitemid 16252644)
32. Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, Uren R, Morgan PO, Fabri LJ, Zhang JG, Martin HM, Willson TA et al. 2002 Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. Journal of Biological Chemistry 277 40181-40184. (doi:10.1074/jbc.C200450200) (Pubitemid 35215586)
33. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA et al. 2005 SOCS2 negatively regulates growth hormone action in vitro and in vivo. Journal of Clinical Investigation 115 397-406. (doi:10.1172/JCI22710) (Pubitemid 40385481)
34. Guicheux J, Heymann D, Rousselle AV, Gouin F, Pilet P, Yamada S & Daculsi G 1998 Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. Bone 22 25-31. (doi:10.1016/S8756-3282(97)00224-X) (Pubitemid 28033649)
35. Hansen JA, Lindberg K, Hilton DJ, Nielsen JH & Billestrup N 1999 Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Molecular Endocrinology 13 1832-1843. (doi:10.1210/me.13.11.1832) (Pubitemid 30645257)
36. Hayashi T, Kaneda T, Toyama Y, Kumegawa M & Hakeda Y 2002 Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation. Journal of Biological Chemistry 277 27880-27886. (doi:10.1074/jbc.M203836200) (Pubitemid 34966734)
37. Herrington J, Smit LS, Schwartz J & Carter-Su C 2000 The role of STAT proteins in growth hormone signaling. Oncogene 19 2585-2597. (doi:10.1038/sj.onc.1203526) (Pubitemid 30339214)
38. Hildebrand T & Rüegsegger P 1997 Quantification of bone microarchitecture with the structure model index. Computer Methods in Biomechanics and Biomedical Engineering 1 15-23. (doi:10.1080/01495739708936692)
39. Hilton DJ 1999 Negative regulators of cytokine signal transduction. Cellular and Molecular Life Sciences 55 1568-1577. (doi:10.1007/s000180050396)
40. Holly J & Perks C 2006 The role of insulin-like growth factor binding proteins. Neuroendocrinology 83 154-160. (doi:10.1159/000095523) (Pubitemid 44578867)
41. Horvat S & Medrano JF 1995 Interval mapping of high growth (hg), a major locus that increases weight gain in mice. Genetics 139 1737-1748.
42. Horvat S & Medrano JF 1998 A 500-kb YAC and BAC contig encompassing the high-growth deletion in mouse chromosome 10 and identification of the murine Raidd/Cradd gene in the candidate region. Genomics 54 159-164. (doi:10.1006/geno.1998.5540) (Pubitemid 28536207)
43. Horvat S & Medrano JF 2001 Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72 209-212. (doi:10.1006/geno.2000.6441) (Pubitemid 32242961)
44. Hou P, Sato T, Hofstetter W & Foged NT 1997 Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts. Journal of Bone and Mineral Research 12 534-540. (doi:10.1359/jbmr.1997.12.4.534) (Pubitemid 27155212)
45. Hunziker EB, Wagner J & Zapf J 1994 Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. Journal of Clinical Investigation 93 1078-1086. (doi:10.1172/JCI117058) (Pubitemid 24087160)
46. Ihle JN & Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends in Genetics 11 69-74. (doi:10.1016/S0168-9525(00) 89000-9)
47. Isaksson OG, Jansson JO & Gause IA 1982 Growth hormone stimulates longitudinal bone growth directly. Science 216 1237-1239. (doi:10.1126/science. 7079756)
48. Isgaard J, Nilsson A, Lindahl A, Jansson JO & Isaksson OG 1986 Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. American Journal of Physiology 250 E367-E372.
49. Jasmin JF, Mercier I, Sotgia F&Lisanti MP 2006 SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. Trends in Endocrinology and Metabolism 17 150-158. (doi:10.1016/j.tem.2006.03.007)
50. Kanatani M, Sugimoto T, Nishiyama K & Chihara K 2000 Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity. Journal of Bone and Mineral Research 15 902-910. (doi:10.1359/jbmr.2000.15.5.902) (Pubitemid 30233414)
51. Kassem M, Brixen K, Blum WF, Mosekilde L & Eriksen EF 1994 Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. Journal of Bone and Mineral Research 9 1365-1370. (doi:10.1002/jbmr.5650090907) (Pubitemid 24268847)
52. Klammt J, Pfäffle R, Werner H & Kiess W 2008 IGF signaling defects as causes of growth failure and IUGR. Trends in Endocrinology and Metabolism 19 197-205. (doi:10.1016/j.tem.2008.03.003) (Pubitemid 351993012)
53. Krishnan V, Bryant HU &Macdougald OA 2006 Regulation of bone mass by Wnt signaling. Journal of Clinical Investigation 116 1202-1209. (doi:10.1172/JCI28551)
54. Leaman DW, Leung S, Li X & Stark GR 1996 Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB Journal 10 1578-1588. (Pubitemid 27043774)
55. Leong GM, Moverare S, Brce J, Doyle N, Sjögren K, Dahlman-Wright K, Gustafsson JA, Ho KK, Ohlsson C & Leung KC 2004 Estrogen up-regulates hepatic expression of suppressors of cytokine signaling-2 and -3 in vivo and in vitro. Endocrinology 145 5525-5531. (doi:10.1210/en.2004-0061) (Pubitemid 39564592)
56. Liu JP, Baker J, Perkins AS, Robertson EJ & Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 59-72. (Pubitemid 23306021)
57. Lorentzon M, Greenhalgh CJ, Mohan S, Alexander WS & Ohlsson C 2005 Reduced bone mineral density in SOCS-2-deficient mice. Pediatric Research 57 223-226. (doi:10.1203/01.PDR.0000148735.21084.D3) (Pubitemid 40165599)
58. Lovibond AC, Haque SJ, Chambers TJ & Fox SW 2003 TGF-beta-induced SOCS3 expression augments TNF-alpha-induced osteoclast formation. Biochemical and Biophysical Research Communications 309 762-767. (doi:10.1016/j.bbrc.2003. 08.068)
59. Lupu F, Terwilliger JD, Lee K, Segre GV & Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Developmental Biology 229 141-162. (doi:10.1006/dbio.2000.9975) (Pubitemid 32061720)
60. Macrae VE, Horvat S, Pells SC, Dale H, Collinson RS, Pitsillides AA, Ahmed SF & Farquharson C 2009 Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice. Journal of Cellular Physiology 218 276-284. (doi:10.1002/jcp.21593)
61. Madsen K, Friberg U, Roos P, Edén S & Isaksson O 1983 Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage. Nature 304 545-547. (doi:10.1038/304545a0) (Pubitemid 13026954)
62. Makower AM, Wroblewski J & Pawlowski A 1989 Effects of IGF-I, rGH, FGF, EGF and NCS on DNA-synthesis, cell proliferation and morphology of chondrocytes isolated from rat rib growth cartilage. Cell Biology International Reports 13 259-270. (doi:10.1016/0309-1651(89)90148-3)
63. Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A et al. 1999 SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98 617-627. (doi:10.1016/S0092- 8674(00)80049-5) (Pubitemid 29418953)
64. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL & Palmiter RD 1988a Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123 2827-2833. (doi:10.1210/endo- 123-6-2827)
65. Mathews LS, Hammer RE, Brinster RL & Palmiter RD 1988b Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123 433-437. (doi:10.1210/endo-123-1-433)
66. Metcalf D, Alexander WS, Elefanty AG, Nicola NA, Hilton DJ, Starr R, Mifsud S & Di Rago L 1999 Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia 13 926-934. (doi:10.1038/sj.leu.2401376) (Pubitemid 29292144)
67. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, Nicola NA, Hilton DJ & Alexander WS 2000 Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405 1069-1073. (doi:10.1038/35016611) (Pubitemid 30447793)
68. Michaylira CZ, Simmons JG, Ramocki NM, Scull BP, McNaughton KK, Fuller CR & Lund PK 2006 Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. American Journal of Physiology. Gastrointestinal and Liver Physiology 291 G472-G481. (doi:10.1152/ajpgi.00218. 2005)
69. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K & Kumegawa M 1992 Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131 1075-1080. (doi:10.1210/en.131.3. 1075)
70. Morales O, Faulds MH, Lindgren UJ & Haldosén LA 2002 1α,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. Journal of Biological Chemistry 277 34879-34884. (doi:10.1074/jbc. M204819200)
71. Mushtaq T, Bijman P, Ahmed SF & Farquharson C 2004 Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures. Endocrinology 145 2478-2486. (doi:10.1210/en.2003-1435) (Pubitemid 38535075)
72. Nilsson A, Carlsson B, Isgaard J, Isaksson OG & Rymo L 1990 Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization. Journal of Endocrinology 125 67-74. (doi:10.1677/joe.0.1250067) (Pubitemid 20129790)
73. Nilsson O, Mitchum RD Jr, Schrier L, Ferns SP, Barnes KM, Troendle JF & Baron J 2005 Growth plate senescence is associated with loss of DNA methylation. Journal of Endocrinology 186 241-249. (doi:10.1677/joe.1.06016) (Pubitemid 41015681)
74. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J & Pintar JE 2006 Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Molecular Endocrinology 20 2173-2186. (doi:10.1210/me.2005-0196) (Pubitemid 44286712)
75. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T & Chihara K 1996 Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 137 35-41. (doi:10.1210/en.137.1.35) (Pubitemid 26004970)
76. Ohishi M, Matsumura Y, Aki D, Mashima R, Taniguchi K, Kobayashi T, Kukita T, Iwamoto Y & Yoshimura A 2005 Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines. Journal of Immunology 174 3024-3031. (Pubitemid 40279723)
77. Ouyang X, Fujimoto M, Nakagawa R, Serada S, Tanaka T, Nomura S, Kawase I, Kishimoto T & Naka T 2006 SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. Journal of Cellular Physiology 207 428-436. (doi:10.1002/jcp.20579)
78. Pagani S, Meazza C, Travaglino P, De Benedetti F, Tinelli C & Bozzola M 2005 Serum cytokine levels in GH-deficient children during substitutive GH therapy. European Journal of Endocrinology 152 207-210. (doi:10.1530/eje.1. 01827) (Pubitemid 40309566)
79. Parker EA, Hegde A, Buckley M, Barnes KM, Baron J & Nilsson O 2007 Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. Journal of Endocrinology 194 31-40. (doi:10.1677/JOE-07-0012) (Pubitemid 47162884)
80. Pass C, MacRae VE, Ahmed SF & Farquharson C 2009 Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochemistry and Function 27 119-127. (doi:10.1002/cbf.1551)
81. Piessevaux J, Lavens D, Montoye T, Wauman J, Catteeuw D, Vandekerckhove J, Belsham D, Peelman F & Tavernier J 2006 Functional cross-modulation between SOCS proteins can stimulate cytokine signaling. Journal of Biological Chemistry 281 32953-32966. (doi:10.1074/jbc.M600776200) (Pubitemid 46036680)
82. Playford MP, Bicknell D, Bodmer WF & Macaulay VM 2000 Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. PNAS 97 12103-12108. (doi:10.1073/pnas.210394297)
83. Ram PA & Waxman DJ 1999 SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. Journal of Biological Chemistry 274 35553-35561. (doi:10.1074/jbc.274.50.35553)
84. Reinecke M, Schmid AC, Heyberger-Meyer B, Hunziker EB & Zapf J 2000 Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-Imessenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 141 2847-2853. (doi:10.1210/en.141.8.2847) (Pubitemid 32250447)
85. Renier G, Clément I, Desfaits AC & Lambert A 1996 Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production. Endocrinology 137 4611-4618. (doi:10.1210/en.137.11.4611) (Pubitemid 26403296)
86. Rico-Bautista E, Flores-Morales A & Fernandez-Perez L 2006 Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine and Growth Factor Reviews 17 431-439. (doi:10.1016/j.cytogfr.2006.09.008) (Pubitemid 44793121)
87. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ & Alexander WS 2001 Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. PNAS 98 9324-9329. (doi:10.1073/pnas.161271798) (Pubitemid 32743915)
88. Salmon WD Jr & Daughday WH 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine 49 825-836.
89. Scheven BA & Hamilton NJ 1991 Longitudinal bone growth in vitro: effects of insulin-like growth factor I and growth hormone. Acta Endocrinologica 124 602-607.
90. Schlechter NL, Russell SM, Greenberg S, Spencer EM & Nicoll CS 1986 A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. American Journal of Physiology 250 E231-E235.
91. Shinar DM, Endo N, Halperin D, Rodan GA &Weinreb M 1993 Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132 1158-1167. (doi:10.1210/en.132.3.1158) (Pubitemid 23068632)
92. Sims NA, Clément-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J et al. 2000 Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. Journal of Clinical Investigation 106 1095-1103. (doi:10.1172/JCI10753)
93. Sjögren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Törnell J, Isaksson OG, Jansson JO et al. 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. PNAS 96 7088-7092. (doi:10.1073/pnas.96.12.7088)
94. Slootweg MC, Most WW, van Beek E, Schot LP, Papapoulos SE & Löwik CW 1992 Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. Journal of Endocrinology 132 433-438. (doi:10.1677/joe.0.1320433)
95. Smeets RL, Veenbergen S, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB & van de Loo FA 2006 A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis and Rheumatism 54 1518-1528. (doi:10.1002/art.21752)
96. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ &Alexander WS 1998 Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. PNAS 95 14395-14399. (doi:10.1073/pnas.95.24.14395) (Pubitemid 28549378)
97. Stoecklin E, Wissler M, Schaetzle D, Pfitzner E & Groner B 1999 Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. Journal of Steroid Biochemistry and Molecular Biology 69 195-204. (doi:10.1016/S0960-0760(99)00052-7) (Pubitemid 29305537)
98. Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A & Efstratiadis A 2008 The hormonal action of IGF1 in postnatal mouse growth. PNAS 105 19378-19383. (doi:10.1073/pnas.0809223105)
99. Swolin D & Ohlsson C 1996 Growth hormone increases interleukin-6 produced by human osteoblast-like cells. Journal of Clinical Endocrinology and Metabolism 81 4329-4333. (doi:10.1210/jc.81.12.4329) (Pubitemid 26412038)
100. Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Sahlin L & Norstedt G 1999 Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140 3693-3704. (doi:10.1210/en.140.8.3693)
101. Trippel SB, Van Wyk JJ & Mankin HJ 1986 Localization of somatomedin-C binding to bovine growth-plate chondrocytes in situ. Journal of Bone and Joint Surgery. American Volume 68 897-903.
102. Ueland T 2005 GH/IGF-I and bone resorption in vivo and in vitro. European Journal of Endocrinology 152 327-332. (doi:10.1530/eje.1.01874) (Pubitemid 40439482)
103. Uronen-Hansson H, Allen ML, Lichtarowicz-Krynska E, Aynsley-Green A, Cole TJ, Höidén-Guthenberg I, Fryklund L & Klein N 2003 Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood. Growth Hormone & IGF Research 13 282-286. (doi:10.1016/S1096-6374(03) 00034-0) (Pubitemid 37161683)
104. Walters TD & Griffiths AM 2009 Mechanisms of growth impairment in pediatric Crohn's disease. Nature Reviews. Gastroenterology and Hepatology 6 513-523. (doi:10.1038/nrgastro.2009.124)
105. Wang E, Wang J, Chin E, Zhou J & Bondy CA 1995 Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. Endocrinology 136 2741-2751. (doi:10.1210/en.136.6.2741)
106. Wang J, Zhou J & Bondy CA 1999 Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB Journal 13 1985-1990. (Pubitemid 29517628)
107. Wang J, Zhou J, Cheng CM, Kopchick JJ & Bondy CA 2004 Evidence supporting dual, IGF I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. Journal of Endocrinology 180 247-255. (doi:10.1677/joe.0.1800247) (Pubitemid 38312605)
108. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, Freathy RM, Perry JR, Stevens S, Hall AS et al. 2008 Genome-wide association analysis identifies 20 loci that influence adult height. Nature Genetics 40 575-583. (doi:10.1038/ng.121) (Pubitemid 351601210)
109. Woelfle J, Chia DJ & Rotwein P 2003 Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. Journal of Biological Chemistry 278 51261-51266. (doi:10.1074/jbc.M309486200) (Pubitemid 38020363)
110. Won W & Powell-Braxton L 1998 Insulin-like growth factor gene targeting. In Molecular mechanisms to Regulate the Activities of Insulin-like Growth Factors, pp 57-63. Eds T Katano, N Hizuka & SI Takahashi. Elsevier: Amsterdam.
111. Wong SC, Hassan K, McGrogan P, Weaver LT & Ahmed SF 2007 The effects of recombinant human growth hormone on linear growth in children with Crohn's disease and short stature. Journal of Pediatric Endocrinology and Metabolism 20 1315-1324.
112. Wong SC, MacRae VE, Gracie JA, McInnes IB, Galea P, Gardner-Medwin J & Ahmed SF 2008 Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis. Growth Hormone & IGF Research 18 369-378. (doi:10.1016/j.ghir.2008.01.006) (Pubitemid 351944032)
113. Wong SC, Smyth A, McNeill E, Galloway PJ, Hassan K, McGrogan P & Ahmed SF 2010 The growth hormone-insulin like growth factor 1 axis in children& adolescents with inflammatory bowel disease & growth retardation. Clinical Endocrinology 73 220-228. (doi:10.1111/j.1365-2265.2010. 03799.x)
114. Wu Y, Sun H, Yakar S & LeRoith D 2009 Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice. Endocrinology 150 4395-4403. (doi:10.1210/en.2009-0272)
115. Yakar S, Canalis E, Sun H, Mejia W, Kawashima Y, Nasser P, Courtland HW, Williams V, Bouxsein M, Rosen C et al. 2009 Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. Journal of Bone and Mineral Research 24 1481-1492. (doi:10.1359/jbmr.090226)
116. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B & LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. PNAS 96 7324-7329. (doi:10.1073/pnas.96.13.7324) (Pubitemid 29299660)
117. Zezulak KM & Green H 1986 The generation of insulin-like growth factor-1 - sensitive cells by growth hormone action. Science 233 551-553. (doi:10.1126/science.3726546) (Pubitemid 16019908)
118. Zhang CZ, Young WG, Li H, Clayden AM, Garcia-Aragon J & Waters MJ 1992 Expression of growth hormone receptor by immunocytochemistry in rat molar root formation and alveolar bone remodeling. Calcified Tissue International 50 541-546. (doi:10.1007/BF00582170)
119. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G et al. 1999 The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. PNAS 96 2071-2076. (doi:10.1073/pnas.96.5.2071) (Pubitemid 29117869)
120. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A et al. 2002 Osteoblastspecific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. Journal of Biological Chemistry 277 44005-44012. (doi:10.1074/jbc.M208265200) (Pubitemid 36157826)
121. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH et al. 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141 2674-2682. (doi:10.1210/en.141.7.2674) (Pubitemid 32269089)